SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-007444
Filing Date
2022-05-05
Accepted
2022-05-05 17:01:03
Documents
61
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q xncr-20220331x10q.htm   iXBRL 10-Q 1507509
2 EX-31.1 xncr-20220331xex31d1.htm EX-31.1 17006
3 EX-31.2 xncr-20220331xex31d2.htm EX-31.2 16940
4 EX-32.1 xncr-20220331xex32d1.htm EX-32.1 10013
  Complete submission text file 0001558370-22-007444.txt   7081531

Data Files

Seq Description Document Type Size
5 EX-101.SCH xncr-20220331.xsd EX-101.SCH 42886
6 EX-101.CAL xncr-20220331_cal.xml EX-101.CAL 54174
7 EX-101.DEF xncr-20220331_def.xml EX-101.DEF 205020
8 EX-101.LAB xncr-20220331_lab.xml EX-101.LAB 434346
9 EX-101.PRE xncr-20220331_pre.xml EX-101.PRE 336951
55 EXTRACTED XBRL INSTANCE DOCUMENT xncr-20220331x10q_htm.xml XML 1410696
Mailing Address 111 WEST LEMON AVE MONROVIA CA 91016
Business Address 111 WEST LEMON AVE MONROVIA CA 91016 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

IRS No.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36182 | Film No.: 22897477
SIC: 2834 Pharmaceutical Preparations